These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11264729)

  • 21. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidic inhibitors of the hepatitis C virus serine protease within non-structural protein 3.
    Fischmann TO; Weber PC
    Curr Pharm Des; 2002; 8(28):2533-40. PubMed ID: 12369938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell transformation and proteome alteration in QSG7701 cells transfected with hepatitis C virus non-structural protein 3.
    He Q; Cheng R; Chen Z; Xiao X; Xiao Z; Li C; Li B; Zhang P; Zheng H; Feng D
    Acta Biochim Biophys Sin (Shanghai); 2007 Oct; 39(10):751-62. PubMed ID: 17928924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Point Mutation in the N-Terminal Amphipathic Helix α
    Yan Y; He Y; Boson B; Wang X; Cosset FL; Zhong J
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR and docking studies of HCV NS3 serine protease inhibitors.
    da Cunha EF; Matos KS; Ramalho TC
    Med Chem; 2013 Sep; 9(6):774-805. PubMed ID: 23140577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo assay for hepatitis C viral serine protease activity using a secreted protein.
    Cho YG; Yang SH; Sung YC
    J Virol Methods; 1998 May; 72(1):109-15. PubMed ID: 9672138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation.
    Pan RY; Hung TM; Kou YH; Chan NL; Chang MF; Chang SC
    FEBS Lett; 2010 Feb; 584(3):482-6. PubMed ID: 19958771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection.
    Chen SH; Tan SL
    Curr Med Chem; 2005; 12(20):2317-42. PubMed ID: 16181135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Establishment and the significance of a cell model of secreted alkaline phosphatase co-controlled by HCV 5'NCR and NS3 serine protease].
    Liu SP; Tan DM; Yang YF; Hou ZH
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):552-3. PubMed ID: 15387910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconstitution of hepatitis C virus protease activities in yeast.
    Mak P; Palant O; Labonté P; Plotch S
    FEBS Lett; 2001 Aug; 503(1):13-8. PubMed ID: 11513846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.
    Barbato G; Cicero DO; Cordier F; Narjes F; Gerlach B; Sambucini S; Grzesiek S; Matassa VG; De Francesco R; Bazzo R
    EMBO J; 2000 Mar; 19(6):1195-206. PubMed ID: 10716920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The possible role of NS3 protease activity of hepatitis C virus on fibrogenesis and miR-122 expression in hepatic stellate cells.
    Khanizadeh S; Ravanshad M; Hosseini SY; Davoodian P; Zadeh AN; Sabahi F; Sarvari J; Khanlari Z; Hasani-Azad M
    Acta Virol; 2016; 60(3):242-8. PubMed ID: 27640434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodies.
    Zemel R; Berdichevsky Y; Bachmatov L; Benhar I; Tur-Kaspa R
    J Hepatol; 2004 Jun; 40(6):1000-7. PubMed ID: 15158342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.
    Liu R; Abid K; Pichardo J; Pazienza V; Ingravallo P; Kong R; Agrawal S; Bogen S; Saksena A; Cheng KC; Prongay A; Njoroge FG; Baroudy BM; Negro F
    J Antimicrob Chemother; 2007 Jan; 59(1):51-8. PubMed ID: 17151003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
    Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
    Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease.
    Perni RB; Almquist SJ; Byrn RA; Chandorkar G; Chaturvedi PR; Courtney LF; Decker CJ; Dinehart K; Gates CA; Harbeson SL; Heiser A; Kalkeri G; Kolaczkowski E; Lin K; Luong YP; Rao BG; Taylor WP; Thomson JA; Tung RD; Wei Y; Kwong AD; Lin C
    Antimicrob Agents Chemother; 2006 Mar; 50(3):899-909. PubMed ID: 16495249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.